Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.015 AUD
−1.52 M AUD
49.63 M AUD
80.41 M
About ACUSENSUS LIMITED.
Sector
Industry
CEO
Alexander Jannink
Website
Headquarters
Melbourne
Founded
2018
ISIN
AU0000259582
FIGI
BBG00YD0P529
Acusensus Ltd. engages in the provision of automated camera enforcement technology. It reduces preventable road trauma. The firm offers solutions such as data security and case studies. The company was founded by Ravin Ajit Mirchandani in 2018 and is headquartered in Melbourne, Australia.
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of ACE is 0.970 AUD — it has decreased by −0.51% in the past 24 hours. Watch ACUSENSUS LIMITED. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange ACUSENSUS LIMITED. stocks are traded under the ticker ACE.
ACE stock has fallen by −1.72% compared to the previous week, the month change is a −11.42% fall, over the last year ACUSENSUS LIMITED. has showed a 45.86% increase.
We've gathered analysts' opinions on ACUSENSUS LIMITED. future price: according to them, ACE price has a max estimate of 1.50 AUD and a min estimate of 1.23 AUD. Watch ACE chart and read a more detailed ACUSENSUS LIMITED. stock forecast: see what analysts think of ACUSENSUS LIMITED. and suggest that you do with its stocks.
ACE stock is 0.83% volatile and has beta coefficient of 1.09. Track ACUSENSUS LIMITED. stock price on the chart and check out the list of the most volatile stocks — is ACUSENSUS LIMITED. there?
Yes, you can track ACUSENSUS LIMITED. financials in yearly and quarterly reports right on TradingView.
ACUSENSUS LIMITED. is going to release the next earnings report on Aug 21, 2025. Keep track of upcoming events with our Earnings Calendar.
ACE net income for the last half-year is −511.00 K AUD, while the previous report showed −1.28 M AUD of net income which accounts for 60.13% change. Track more ACUSENSUS LIMITED. financial stats to get the full picture.
No, ACE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ACUSENSUS LIMITED. EBITDA is 4.48 M AUD, and current EBITDA margin is 8.69%. See more stats in ACUSENSUS LIMITED. financial statements.
Like other stocks, ACE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ACUSENSUS LIMITED. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ACUSENSUS LIMITED. technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ACUSENSUS LIMITED. stock shows the buy signal. See more of ACUSENSUS LIMITED. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.